Adjusted win ratio with stratification: Calculation methods and interpretation
Author:
Affiliation:
1. AstraZeneca R&D, Mölndal, Sweden
2. AstraZeneca R&D, Gaithersburg, USA
3. Department of Biostatistics, University of North Carolina, Chapel Hill, USA
Abstract
Publisher
SAGE Publications
Subject
Health Information Management,Statistics and Probability,Epidemiology
Link
http://journals.sagepub.com/doi/pdf/10.1177/0962280220942558
Reference33 articles.
1. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
2. A win ratio approach to comparing continuous non-normal outcomes in clinical trials
3. A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components
4. The stratified win ratio
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Defining estimand for the win ratio: Separate the true effect from censoring;Clinical Trials;2024-07-30
2. Trial Design with Win Statistics for Multiple Time-to-Event Endpoints with Hierarchy;Statistics in Biopharmaceutical Research;2024-07-15
3. Basic Data Structure for Hierarchical Composite Endpoints: An Application to Kidney Disease Trials;Journal of the Society for Clinical Data Management;2024-02-08
4. Adjusted win ratio using the inverse probability of treatment weighting;Journal of Biopharmaceutical Statistics;2023-11-10
5. Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression;Journal of the American Society of Nephrology;2023-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3